Acutaas Chemicals Q2 Results: Multibagger stock jumps 12% after increasing FY27 revenue, margin guidance

Acutaas Chemicals attributed the growth during the quarter to continued momentum in our Pharmaceutical Intermediates business, which was offset by softer performance in the…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)